191 related articles for article (PubMed ID: 16112911)
21. DNA vaccination against tumors.
Prud'homme GJ
J Gene Med; 2005 Jan; 7(1):3-17. PubMed ID: 15538731
[TBL] [Abstract][Full Text] [Related]
22. Antigen epitope-expressing cytokines for DNA immunization.
He X; Tsang TC; Zhang T; Luo P; Harris DT
Vaccine; 2005 Mar; 23(16):1966-72. PubMed ID: 15734069
[TBL] [Abstract][Full Text] [Related]
23. A novel DNA vaccine based on ubiquitin-proteasome pathway targeting 'self'-antigens expressed in melanoma/melanocyte.
Zhang M; Obata C; Hisaeda H; Ishii K; Murata S; Chiba T; Tanaka K; Li Y; Furue M; Chou B; Imai T; Duan X; Himeno K
Gene Ther; 2005 Jul; 12(13):1049-57. PubMed ID: 15800663
[TBL] [Abstract][Full Text] [Related]
24. Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis.
Ruffini PA; Biragyn A; Coscia M; Harvey LK; Cha SC; Bogen B; Kwak LW
J Leukoc Biol; 2004 Jul; 76(1):77-85. PubMed ID: 15075363
[TBL] [Abstract][Full Text] [Related]
25. [Establishment of mouse melanoma model expressing beta-galactosidase and its application in the research of DNA vaccines against tumor].
Jin GX; Gong XG; Huang Q; Fei J
Shi Yan Sheng Wu Xue Bao; 2004 Oct; 37(5):339-43. PubMed ID: 15636360
[TBL] [Abstract][Full Text] [Related]
26. DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis.
Reisfeld RA; Niethammer AG; Luo Y; Xiang R
Immunol Rev; 2004 Jun; 199():181-90. PubMed ID: 15233734
[TBL] [Abstract][Full Text] [Related]
27. DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model.
Zhang H; Wang Y; Liu C; Zhang L; Xia Q; Zhang Y; Wu J; Jiang C; Chen Y; Wu Y; Zha X; Yu X; Kong W
Cancer Immunol Immunother; 2012 Oct; 61(10):1857-67. PubMed ID: 22706381
[TBL] [Abstract][Full Text] [Related]
28. A novel anticancer approach: SEA-anchored tumor cells expressing heat shock protein 70 onto the surface elicit strong anticancer efficacy.
Huang C; Yu H; Wang Q; Yang G; Ma W; Xia D; Chen X; Yi P; Shen F; Zheng H; Cao X
Immunol Lett; 2005 Oct; 101(1):71-80. PubMed ID: 15908014
[TBL] [Abstract][Full Text] [Related]
29. DNA vaccines: a role for liposomes.
Gregoriadis G
Curr Opin Mol Ther; 1999 Feb; 1(1):39-42. PubMed ID: 11249682
[TBL] [Abstract][Full Text] [Related]
30. Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma.
Tanaka M; Kaneda Y; Fujii S; Yamano T; Hashimoto K; Huang SK; Hoon DS
Mol Ther; 2002 Mar; 5(3):291-9. PubMed ID: 11863419
[TBL] [Abstract][Full Text] [Related]
31. The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.
Quaglino E; Mastini C; Iezzi M; Forni G; Musiani P; Klapper LN; Hardy B; Cavallo F
Vaccine; 2005 May; 23(25):3280-7. PubMed ID: 15837233
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune depigmentation following sensitization to melanoma antigens.
Hurwitz AA; Ji Q
Methods Mol Med; 2004; 102():421-7. PubMed ID: 15286398
[TBL] [Abstract][Full Text] [Related]
33. Specific serological response by active immunization with GD3-bearing liposomes.
Massó O; Aliño SF; Lejarreta M; Blasco F; Piulats J
J Pharmacol Exp Ther; 1996 Sep; 278(3):1114-20. PubMed ID: 8819493
[TBL] [Abstract][Full Text] [Related]
34. Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture.
Eggert AO; Becker JC; Ammon M; McLellan AD; Renner G; Merkel A; Bröcker EB; Kämpgen E
Eur J Immunol; 2002 Jan; 32(1):122-7. PubMed ID: 11754352
[TBL] [Abstract][Full Text] [Related]
35. Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines.
van Slooten ML; Storm G; Zoephel A; Küpcü Z; Boerman O; Crommelin DJ; Wagner E; Kircheis R
Pharm Res; 2000 Jan; 17(1):42-8. PubMed ID: 10714607
[TBL] [Abstract][Full Text] [Related]
36. Induction of autoantibodies against tyrosinase-related proteins following DNA vaccination: unexpected reactivity to a protein paralogue.
Srinivasan R; Houghton AN; Wolchok JD
Cancer Immun; 2002 Jul; 2():8. PubMed ID: 12747753
[TBL] [Abstract][Full Text] [Related]
37. Molecular adjuvants for mucosal immunity.
Toka FN; Pack CD; Rouse BT
Immunol Rev; 2004 Jun; 199():100-12. PubMed ID: 15233729
[TBL] [Abstract][Full Text] [Related]
38. Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model.
Souberbielle BE; Westby M; Ganz S; Kayaga J; Mendes R; Morrow WJ; Dalgleish AG
Gene Ther; 1998 Nov; 5(11):1447-54. PubMed ID: 9930297
[TBL] [Abstract][Full Text] [Related]
39. Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-beta.
Jia ZC; Zou LY; Ni B; Wan Y; Zhou W; Lv YB; Geng M; Wu YZ
Cancer Immunol Immunother; 2005 May; 54(5):446-52. PubMed ID: 15750831
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
Bergman PJ; McKnight J; Novosad A; Charney S; Farrelly J; Craft D; Wulderk M; Jeffers Y; Sadelain M; Hohenhaus AE; Segal N; Gregor P; Engelhorn M; Riviere I; Houghton AN; Wolchok JD
Clin Cancer Res; 2003 Apr; 9(4):1284-90. PubMed ID: 12684396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
